Xavier X Sastre-garau - Nanotechnology

Author Information

Xavier Sastre-Garau is affiliated with the Service de Biopathologie at the Institut de Cancérologie de Lorraine, located in Vandoeuvre-lès-Nancy, France. His research primarily focuses on cancer biology, with a significant emphasis on the molecular and pathological aspects of various carcinomas.

Research Contributions

Xavier Sastre-Garau has made substantial contributions to the field of cancer research, particularly in understanding the molecular mechanisms underlying different types of carcinomas. His work includes studies on ovarian cancer aggressivity, the use of next-generation sequencing (NGS) for diagnosing HPV-associated carcinomas, and the identification of tumor markers in vulvar carcinoma. He has also explored the expression of immune response biomarkers in recurrent head and neck squamous cell carcinoma and the role of HPV ctDNA in cervical cancer treatment. His research has been published in several high-impact journals, highlighting his contributions to advancing the field of oncology.

Aliases

Xavier Sastre-Garau is also known by several aliases, including Xavier X Sastre-garau, Xavier Sastre-garau, X. Sastre-garau, X Sastre-garau, Xavier Sastre-garau, and X. Sastre-garau.

Publication and Citation Metrics

Metric	Value
Total Citation Count	15,658
H-Index	71
Number of Papers	290

Publications:

Low centrosome numbers correlate with higher aggressivity in ovarian cancer

DOI: 10.1101/623983

Year: 2022

A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization

DOI: 10.1158/1078-0432.CCR-21-0293

Year: 2021

A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression

DOI: 10.1038/s41467-021-25792-0

Year: 2021

Vulvar Basal Cell Carcinoma: Clinical and Histopathologic Features.

DOI: 10.1097/PGP.0000000000000771

Year: 2021

Respective prevalence of high‐risk HPVgenotypes in cervical neoplasia in Senegal

DOI: 10.1002/jmv.27020

Year: 2021

Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.

DOI: 10.3892/or.2021.7928

Year: 2021

CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients

DOI: 10.3390/cancers13163928

Year: 2021

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

DOI: 10.1016/j.esmoop.2021.100154

Year: 2021

Identification of Specific Tumor Markers in Vulvar Carcinoma Through Extensive Human Papillomavirus DNA Characterization Using Next Generation Sequencing Method.

DOI: 10.1097/LGT.0000000000000498

Year: 2020

Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients

DOI: 10.1038/s41467-020-17046-2

Year: 2020

How Are These Airbags Tested?

What is Curriculum Standardization in Nanotechnology?

How is Nanotechnology Revolutionizing SHM?

Why are Gold Nanoparticles Important?

How Can We Measure the Impact of Outreach Programs?

How Does Nanotechnology Improve Telecommunication Devices?

Who Can Become a Member?

How Does Interconnect Length Affect Signal Propagation?

Is there a problem with public perception and understanding?

What are Enhanced Algorithms?

Partnered Content Networks

Relevant Topics